Skip to main content

PacBio Partners with Imec to Develop Microchips for SMRT Technology

NEW YORK (GenomeWeb News) — Pacific Biosciences and Imec, a Belgian nanoelectronics research firm, are collaborating on developing advanced microchips for highly multiplexed single-molecule genetic analysis, the firms said today.

The goal of the multi-year research collaboration is to scale the capacity and throughput of PacBio's single-molecule real-time technology, PacBio President and CEO Michael Hunkapiller said in a statement.

Imec will help identify ways to bring greater economies of scale to PacBio's technology through nanoscale semiconductor fabrication, said Luc Van den hove, president and CEO of Imec.

The partners will combine PacBio's zero-mode waveguide technology and Imec's expertise in nanophotonics, CMOS sensors, technology integration, and fabrication.

Imec, headquartered in Leuven, performs research in nanoelectronics and has international partnerships in the areas of information and communications technology, healthcare, and energy. The company has a staff of almost 2,000, including more than 600 industrial residents and guest researchers. Last year, Imec had about €300 million ($363 million) in revenue.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.